Ratings of the last 12 months
This list shows every rating MEQIRI has published for a stock, an ETF or a coin, and every change between Strong, Neutral and Weak. For stocks it also shows every valuation signal and its changes.
Counted from the public launch on 7 Nov 2026.
- Price target: none, MEQIRI does not give price targets.
- Fair value: for the valuation signal, that day's fair value, converted like the price. An estimate from the disclosed model, not a price target.
- Validity: until the rating or the valuation signal changes, time horizon about 12 months, recalculated every night.
- Price: last close before publication, converted into dollars at that day's ECB rate; ETFs in euros.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
14,177 entries
- AT&T Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $49.52, $21.63
- ATCO Ltd.7 Nov 2026Neutral (first rating), Score 53, $60.64
- ATCO Ltd.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $44.73, $60.64
- ATI Inc.7 Nov 2026Neutral (first rating), Score 63, $175.79
- ATI Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $117.10, $175.79
- ATN International, Inc.7 Nov 2026Neutral (first rating), Score 69, $28.02
- ATN International, Inc.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $108.53, $28.02
- ATOSS Software AG7 Nov 2026Strong (first rating), Score 82, $99.26
- ATOSS Software AG7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $96.56, $99.26
- ATRenew Inc.7 Nov 2026Neutral (first rating), Score 61, $4.45
- ATRenew Inc.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $13.09, $4.45
- ATS Corporation7 Nov 2026Weak (first rating), Score 41, $16.97
- ATS Corporation7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $35.17, $16.97
- AU Small Finance Bank Limited7 Nov 2026Neutral (first rating), Score 67, $9.92
- AU Small Finance Bank Limited7 Nov 2026Valuation signal Overvalued (first signal), Fair value $6.58, $9.92
- AUO Corporation7 Nov 2026Weak (first rating), Score 34, NT$26.55
- AUO Corporation7 Nov 2026Valuation signal Overvalued (first signal), Fair value not meaningful, NT$26.55
- AUTO1 Group SE7 Nov 2026Weak (first rating), Score 40, $19.48
- AUTO1 Group SE7 Nov 2026Valuation signal Overvalued (first signal), Fair value $8.30, $19.48
- AVA (Travala)7 Nov 2026Neutral (first rating), Score 55, $0.27
- AVIC Airborne Systems Co., Ltd.7 Nov 2026Weak (first rating), Score 44, $1.73
- AVIC Airborne Systems Co., Ltd.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $0.57, $1.73
- AVIC Chengdu Aircraft Company Limited7 Nov 2026Weak (first rating), Score 49, $10.49
- AVIC Chengdu Aircraft Company Limited7 Nov 2026Valuation signal Overvalued (first signal), Fair value $2.63, $10.49
- AVIC Jonhon Optronic Technology Co.,Ltd.7 Nov 2026Neutral (first rating), Score 58, $5.10
- AVIC Jonhon Optronic Technology Co.,Ltd.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $2.67, $5.10
- Weak (first rating), Score 44, $3.56
- Valuation signal Overvalued (first signal), Fair value not meaningful, $3.56
- AXA S.A.7 Nov 2026Strong (first rating), Score 73, $49.89
- AXA S.A.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $76.04, $49.89
- AXIA Energia7 Nov 2026Neutral (first rating), Score 52, $8.77
- AXIA Energia7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $6.18, $8.77
- AXIS Capital Holdings Limited7 Nov 2026Strong (first rating), Score 73, $105.97
- AXIS Capital Holdings Limited7 Nov 2026Valuation signal Undervalued (first signal), Fair value $205.91, $105.97
- AXT, Inc.7 Nov 2026Weak (first rating), Score 47, $38.88
- AXT, Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $39.62, $38.88
- AZZ Inc.7 Nov 2026Neutral (first rating), Score 64, $125.71
- AZZ Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $126.05, $125.71
- Aalberts N.V.7 Nov 2026Neutral (first rating), Score 61, $44.86
- Aalberts N.V.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $48.19, $44.86
- Aave7 Nov 2026Neutral (first rating), Score 69, $130.67
- Ab S.a.7 Nov 2026Neutral (first rating), Score 64, $34.31
- Ab S.a.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $60.77, $34.31
- AbCellera Biologics Inc.7 Nov 2026Weak (first rating), Score 38, $11.88
- Abacus Global Management, Inc.7 Nov 2026Neutral (first rating), Score 61, $8.78
- Abacus Global Management, Inc.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $4.27, $8.78
- AbbVie Inc.7 Nov 2026Strong (first rating), Score 71, $291.31
- AbbVie Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $270.52, $291.31
- Abbott India Limited7 Nov 2026Strong (first rating), Score 75, $280.50
- Abbott India Limited7 Nov 2026Valuation signal Overvalued (first signal), Fair value $152.60, $280.50
- Abbott Laboratories7 Nov 2026Neutral (first rating), Score 64, $109.93
- Abbott Laboratories7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $96.96, $109.93
- Abercrombie & Fitch Co.7 Nov 2026Strong (first rating), Score 78, $149.54
- Abercrombie & Fitch Co.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $231.45, $149.54
- Abey7 Nov 2026Weak (first rating), Score 44, $0.04
- Abivax S.A.7 Nov 2026Weak (first rating), Score 33, $86.14
- Absci Corporation7 Nov 2026Weak (first rating), Score 40, $10.17
- Acacia Research Corporation7 Nov 2026Weak (first rating), Score 42, $4.25
- Acacia Research Corporation7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $4.94, $4.25
- AcadeMedia AB (publ)7 Nov 2026Neutral (first rating), Score 66, $12.64
- AcadeMedia AB (publ)7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $16.88, $12.64
- Academy Sports and Outdoors, Inc.7 Nov 2026Strong (first rating), Score 72, $67.27
- Academy Sports and Outdoors, Inc.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $142.27, $67.27
- Acadia Healthcare Company, Inc.7 Nov 2026Weak (first rating), Score 48, $37.00
- Acadia Healthcare Company, Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $27.88, $37.00
- Acadia Pharmaceuticals Inc.7 Nov 2026Neutral (first rating), Score 66, $21.23
- Acadia Pharmaceuticals Inc.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $39.03, $21.23
- Acadia Realty Trust7 Nov 2026Neutral (first rating), Score 53, $19.80
- Acadia Realty Trust7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $20.27, $19.80
- Acadian Asset Management7 Nov 2026Strong (first rating), Score 85, $90.96
- Acadian Asset Management7 Nov 2026Valuation signal Undervalued (first signal), Fair value $140.08, $90.96
- Acast AB (publ)7 Nov 2026Neutral (first rating), Score 52, $2.82
- Acast AB (publ)7 Nov 2026Valuation signal Undervalued (first signal), Fair value $4.31, $2.82
- Accel Entertainment, Inc.7 Nov 2026Neutral (first rating), Score 66, $13.72
- Accel Entertainment, Inc.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $28.89, $13.72
- Accelerant Holdings7 Nov 2026Weak (first rating), Score 37, $19.89
- Accelerant Holdings7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $17.51, $19.89
- Accelink Technologies Co,Ltd.7 Nov 2026Neutral (first rating), Score 54, $13.69
- Accelink Technologies Co,Ltd.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $5.65, $13.69
- Accelleron Industries AG7 Nov 2026Neutral (first rating), Score 69, $77.48
- Accelleron Industries AG7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $70.46, $77.48
- Accenture plc7 Nov 2026Strong (first rating), Score 79, $260.50
- Accenture plc7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $305.58, $260.50
- Acciona, S.A.7 Nov 2026Neutral (first rating), Score 51, $243.40
- Acciona, S.A.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $103.83, $243.40
- Accor S.A.7 Nov 2026Neutral (first rating), Score 66, $55.83
- Accor S.A.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $72.72, $55.83
- Accton Technology Corporation7 Nov 2026Strong (first rating), Score 71, NT$1,280.00
- Accton Technology Corporation7 Nov 2026Valuation signal Undervalued (first signal), Fair value NT$3,199.69, NT$1,280.00
- Acerinox, S.A.7 Nov 2026Weak (first rating), Score 42, $16.68
- Acerinox, S.A.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $8.52, $16.68
- Achieve Life Sciences, Inc.7 Nov 2026Weak (first rating), Score 40, $6.72
- Ackermans & Van Haaren N.V.7 Nov 2026Neutral (first rating), Score 60, $299.22
- Ackermans & Van Haaren N.V.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $308.55, $299.22
- Aclaris Therapeutics, Inc.7 Nov 2026Weak (first rating), Score 39, $3.90
- Acomo N.V.7 Nov 2026Neutral (first rating), Score 60, $25.74
- Acomo N.V.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $43.33, $25.74
- Across Protocol7 Nov 2026Neutral (first rating), Score 51, $0.05
- Acuity Brands, Inc.7 Nov 2026Strong (first rating), Score 78, $323.06
- Acuity Brands, Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $378.74, $323.06
| Date | Security | Rating | Before | Score | Fair value | Price |
|---|---|---|---|---|---|---|
| 7 Nov 2026 | AT&T Inc. T | Valuation signalFairly valued | first signal | $49.52 | $21.63 | |
| 7 Nov 2026 | ATCO Ltd. ACO-X.TO | Neutral | first rating | 53 | $60.64 | |
| 7 Nov 2026 | ATCO Ltd. ACO-X.TO | Valuation signalOvervalued | first signal | $44.73 | $60.64 | |
| 7 Nov 2026 | ATI Inc. ATI | Neutral | first rating | 63 | $175.79 | |
| 7 Nov 2026 | ATI Inc. ATI | Valuation signalFairly valued | first signal | $117.10 | $175.79 | |
| 7 Nov 2026 | ATN International, Inc. ATNI | Neutral | first rating | 69 | $28.02 | |
| 7 Nov 2026 | ATN International, Inc. ATNI | Valuation signalUndervalued | first signal | $108.53 | $28.02 | |
| 7 Nov 2026 | ATOSS Software AG AOF.DE | Strong | first rating | 82 | $99.26 | |
| 7 Nov 2026 | ATOSS Software AG AOF.DE | Valuation signalFairly valued | first signal | $96.56 | $99.26 | |
| 7 Nov 2026 | ATRenew Inc. RERE | Neutral | first rating | 61 | $4.45 | |
| 7 Nov 2026 | ATRenew Inc. RERE | Valuation signalUndervalued | first signal | $13.09 | $4.45 | |
| 7 Nov 2026 | ATS Corporation ATS | Weak | first rating | 41 | $16.97 | |
| 7 Nov 2026 | ATS Corporation ATS | Valuation signalFairly valued | first signal | $35.17 | $16.97 | |
| 7 Nov 2026 | AU Small Finance Bank Limited AUBANK.NS | Neutral | first rating | 67 | $9.92 | |
| 7 Nov 2026 | AU Small Finance Bank Limited AUBANK.NS | Valuation signalOvervalued | first signal | $6.58 | $9.92 | |
| 7 Nov 2026 | AUO Corporation 2409.TW | Weak | first rating | 34 | NT$26.55 | |
| 7 Nov 2026 | AUO Corporation 2409.TW | Valuation signalOvervalued | first signal | not meaningful | NT$26.55 | |
| 7 Nov 2026 | AUTO1 Group SE AG1.DE | Weak | first rating | 40 | $19.48 | |
| 7 Nov 2026 | AUTO1 Group SE AG1.DE | Valuation signalOvervalued | first signal | $8.30 | $19.48 | |
| 7 Nov 2026 | AVA (Travala) AVA | Neutral | first rating | 55 | $0.27 | |
| 7 Nov 2026 | AVIC Airborne Systems Co., Ltd. 600372.SS | Weak | first rating | 44 | $1.73 | |
| 7 Nov 2026 | AVIC Airborne Systems Co., Ltd. 600372.SS | Valuation signalOvervalued | first signal | $0.57 | $1.73 | |
| 7 Nov 2026 | AVIC Chengdu Aircraft Company Limited 302132.SZ | Weak | first rating | 49 | $10.49 | |
| 7 Nov 2026 | AVIC Chengdu Aircraft Company Limited 302132.SZ | Valuation signalOvervalued | first signal | $2.63 | $10.49 | |
| 7 Nov 2026 | AVIC Jonhon Optronic Technology Co.,Ltd. 002179.SZ | Neutral | first rating | 58 | $5.10 | |
| 7 Nov 2026 | AVIC Jonhon Optronic Technology Co.,Ltd. 002179.SZ | Valuation signalOvervalued | first signal | $2.67 | $5.10 | |
| 7 Nov 2026 | AVIC Xi'an Aircraft Industry Group Company Ltd. 000768.SZ | Weak | first rating | 44 | $3.56 | |
| 7 Nov 2026 | AVIC Xi'an Aircraft Industry Group Company Ltd. 000768.SZ | Valuation signalOvervalued | first signal | not meaningful | $3.56 | |
| 7 Nov 2026 | AXA S.A. CS.PA | Strong | first rating | 73 | $49.89 | |
| 7 Nov 2026 | AXA S.A. CS.PA | Valuation signalUndervalued | first signal | $76.04 | $49.89 | |
| 7 Nov 2026 | AXIA Energia AXIA3.SA | Neutral | first rating | 52 | $8.77 | |
| 7 Nov 2026 | AXIA Energia AXIA3.SA | Valuation signalFairly valued | first signal | $6.18 | $8.77 | |
| 7 Nov 2026 | AXIS Capital Holdings Limited AXS | Strong | first rating | 73 | $105.97 | |
| 7 Nov 2026 | AXIS Capital Holdings Limited AXS | Valuation signalUndervalued | first signal | $205.91 | $105.97 | |
| 7 Nov 2026 | AXT, Inc. AXTI | Weak | first rating | 47 | $38.88 | |
| 7 Nov 2026 | AXT, Inc. AXTI | Valuation signalFairly valued | first signal | $39.62 | $38.88 | |
| 7 Nov 2026 | AZZ Inc. AZZ | Neutral | first rating | 64 | $125.71 | |
| 7 Nov 2026 | AZZ Inc. AZZ | Valuation signalFairly valued | first signal | $126.05 | $125.71 | |
| 7 Nov 2026 | Aalberts N.V. AALB.AS | Neutral | first rating | 61 | $44.86 | |
| 7 Nov 2026 | Aalberts N.V. AALB.AS | Valuation signalFairly valued | first signal | $48.19 | $44.86 | |
| 7 Nov 2026 | Aave AAVE | Neutral | first rating | 69 | $130.67 | |
| 7 Nov 2026 | Ab S.a. ABE.WA | Neutral | first rating | 64 | $34.31 | |
| 7 Nov 2026 | Ab S.a. ABE.WA | Valuation signalUndervalued | first signal | $60.77 | $34.31 | |
| 7 Nov 2026 | AbCellera Biologics Inc. ABCL | Weak | first rating | 38 | $11.88 | |
| 7 Nov 2026 | Abacus Global Management, Inc. ABX | Neutral | first rating | 61 | $8.78 | |
| 7 Nov 2026 | Abacus Global Management, Inc. ABX | Valuation signalOvervalued | first signal | $4.27 | $8.78 | |
| 7 Nov 2026 | AbbVie Inc. ABBV | Strong | first rating | 71 | $291.31 | |
| 7 Nov 2026 | AbbVie Inc. ABBV | Valuation signalFairly valued | first signal | $270.52 | $291.31 | |
| 7 Nov 2026 | Abbott India Limited ABBOTINDIA.NS | Strong | first rating | 75 | $280.50 | |
| 7 Nov 2026 | Abbott India Limited ABBOTINDIA.NS | Valuation signalOvervalued | first signal | $152.60 | $280.50 | |
| 7 Nov 2026 | Abbott Laboratories ABT | Neutral | first rating | 64 | $109.93 | |
| 7 Nov 2026 | Abbott Laboratories ABT | Valuation signalFairly valued | first signal | $96.96 | $109.93 | |
| 7 Nov 2026 | Abercrombie & Fitch Co. ANF | Strong | first rating | 78 | $149.54 | |
| 7 Nov 2026 | Abercrombie & Fitch Co. ANF | Valuation signalUndervalued | first signal | $231.45 | $149.54 | |
| 7 Nov 2026 | Abey ABEY | Weak | first rating | 44 | $0.04 | |
| 7 Nov 2026 | Abivax S.A. ABVX.PA | Weak | first rating | 33 | $86.14 | |
| 7 Nov 2026 | Absci Corporation ABSI | Weak | first rating | 40 | $10.17 | |
| 7 Nov 2026 | Acacia Research Corporation ACTG | Weak | first rating | 42 | $4.25 | |
| 7 Nov 2026 | Acacia Research Corporation ACTG | Valuation signalFairly valued | first signal | $4.94 | $4.25 | |
| 7 Nov 2026 | AcadeMedia AB (publ) ACAD.ST | Neutral | first rating | 66 | $12.64 | |
| 7 Nov 2026 | AcadeMedia AB (publ) ACAD.ST | Valuation signalFairly valued | first signal | $16.88 | $12.64 | |
| 7 Nov 2026 | Academy Sports and Outdoors, Inc. ASO | Strong | first rating | 72 | $67.27 | |
| 7 Nov 2026 | Academy Sports and Outdoors, Inc. ASO | Valuation signalUndervalued | first signal | $142.27 | $67.27 | |
| 7 Nov 2026 | Acadia Healthcare Company, Inc. ACHC | Weak | first rating | 48 | $37.00 | |
| 7 Nov 2026 | Acadia Healthcare Company, Inc. ACHC | Valuation signalFairly valued | first signal | $27.88 | $37.00 | |
| 7 Nov 2026 | Acadia Pharmaceuticals Inc. ACAD | Neutral | first rating | 66 | $21.23 | |
| 7 Nov 2026 | Acadia Pharmaceuticals Inc. ACAD | Valuation signalUndervalued | first signal | $39.03 | $21.23 | |
| 7 Nov 2026 | Acadia Realty Trust AKR | Neutral | first rating | 53 | $19.80 | |
| 7 Nov 2026 | Acadia Realty Trust AKR | Valuation signalFairly valued | first signal | $20.27 | $19.80 | |
| 7 Nov 2026 | Acadian Asset Management AAMI | Strong | first rating | 85 | $90.96 | |
| 7 Nov 2026 | Acadian Asset Management AAMI | Valuation signalUndervalued | first signal | $140.08 | $90.96 | |
| 7 Nov 2026 | Acast AB (publ) ACAST.ST | Neutral | first rating | 52 | $2.82 | |
| 7 Nov 2026 | Acast AB (publ) ACAST.ST | Valuation signalUndervalued | first signal | $4.31 | $2.82 | |
| 7 Nov 2026 | Accel Entertainment, Inc. ACEL | Neutral | first rating | 66 | $13.72 | |
| 7 Nov 2026 | Accel Entertainment, Inc. ACEL | Valuation signalUndervalued | first signal | $28.89 | $13.72 | |
| 7 Nov 2026 | Accelerant Holdings ARX | Weak | first rating | 37 | $19.89 | |
| 7 Nov 2026 | Accelerant Holdings ARX | Valuation signalFairly valued | first signal | $17.51 | $19.89 | |
| 7 Nov 2026 | Accelink Technologies Co,Ltd. 002281.SZ | Neutral | first rating | 54 | $13.69 | |
| 7 Nov 2026 | Accelink Technologies Co,Ltd. 002281.SZ | Valuation signalOvervalued | first signal | $5.65 | $13.69 | |
| 7 Nov 2026 | Accelleron Industries AG ACLN.SW | Neutral | first rating | 69 | $77.48 | |
| 7 Nov 2026 | Accelleron Industries AG ACLN.SW | Valuation signalFairly valued | first signal | $70.46 | $77.48 | |
| 7 Nov 2026 | Accenture plc ACN | Strong | first rating | 79 | $260.50 | |
| 7 Nov 2026 | Accenture plc ACN | Valuation signalFairly valued | first signal | $305.58 | $260.50 | |
| 7 Nov 2026 | Acciona, S.A. ANA.MC | Neutral | first rating | 51 | $243.40 | |
| 7 Nov 2026 | Acciona, S.A. ANA.MC | Valuation signalOvervalued | first signal | $103.83 | $243.40 | |
| 7 Nov 2026 | Accor S.A. AC.PA | Neutral | first rating | 66 | $55.83 | |
| 7 Nov 2026 | Accor S.A. AC.PA | Valuation signalFairly valued | first signal | $72.72 | $55.83 | |
| 7 Nov 2026 | Accton Technology Corporation 2345.TW | Strong | first rating | 71 | NT$1,280.00 | |
| 7 Nov 2026 | Accton Technology Corporation 2345.TW | Valuation signalUndervalued | first signal | NT$3,199.69 | NT$1,280.00 | |
| 7 Nov 2026 | Acerinox, S.A. ACX.MC | Weak | first rating | 42 | $16.68 | |
| 7 Nov 2026 | Acerinox, S.A. ACX.MC | Valuation signalOvervalued | first signal | $8.52 | $16.68 | |
| 7 Nov 2026 | Achieve Life Sciences, Inc. ACHV | Weak | first rating | 40 | $6.72 | |
| 7 Nov 2026 | Ackermans & Van Haaren N.V. ACKB.BR | Neutral | first rating | 60 | $299.22 | |
| 7 Nov 2026 | Ackermans & Van Haaren N.V. ACKB.BR | Valuation signalFairly valued | first signal | $308.55 | $299.22 | |
| 7 Nov 2026 | Aclaris Therapeutics, Inc. ACRS | Weak | first rating | 39 | $3.90 | |
| 7 Nov 2026 | Acomo N.V. ACOMO.AS | Neutral | first rating | 60 | $25.74 | |
| 7 Nov 2026 | Acomo N.V. ACOMO.AS | Valuation signalUndervalued | first signal | $43.33 | $25.74 | |
| 7 Nov 2026 | Across Protocol ACX | Neutral | first rating | 51 | $0.05 | |
| 7 Nov 2026 | Acuity Brands, Inc. AYI | Strong | first rating | 78 | $323.06 | |
| 7 Nov 2026 | Acuity Brands, Inc. AYI | Valuation signalFairly valued | first signal | $378.74 | $323.06 |
Legal basis: Article 4(1)(i) of Delegated Regulation (EU) 2016/958.
To the disclosures